Profile | GDS2987 / GI_11342663-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 17.7 | 51 |
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 6.2 | 21 |
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | 22.1 | 46 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 14.2 | 27 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 9.1 | 19 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 14.9 | 25 |
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 26.8 | 42 |
GSM215297 | PASMC_vehicle_rep1 | 28.9 | 41 |
GSM215298 | PASMC_vehicle_rep2 | 36.5 | 49 |
GSM215310 | PASMC_vehicle_rep3 | 28.5 | 42 |
GSM215311 | PASMC_atorvastatin_rep1 | 29 | 45 |
GSM215312 | PASMC_atorvastatin_rep2 | 43.9 | 56 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 41.7 | 56 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 4.4 | 9 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | 38.8 | 55 |
GSM215328 | PASMC_SLx2119_rep2 | 19.4 | 34 |
GSM215329 | PASMC_SLx2119_rep3 | 5.2 | 10 |
GSM215330 | Fibroblasts_vehicle_rep1 | 370 | 87 |
GSM215331 | Fibroblasts_vehicle_rep2 | 422.1 | 88 |
GSM215332 | Fibroblasts_vehicle_rep3 | 337.9 | 87 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 358.6 | 87 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 444.1 | 88 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 384 | 87 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 396.5 | 88 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 372 | 88 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 481 | 89 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 1480.8 | 96 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 1388.5 | 96 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 1343.9 | 96 |